Survival of patients with stage I lung cancer detected on CT screening.

By C. Henschke, D. Yankelevitz, D. Libby, M. Pasmantier, James P. Smith, O. Miettinen. New England Journal of Medicine, 2006

1,684 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Imaging and cancer: A review (2008, methodology): “CT lung cancer screening (Swensen et al., 2003; Henschke et al., 2006, 2007; Henschke, 2007) is used with low dose CT combined with lung nodule analysis software (Figure 7).”
Unique Clinicopathologic Features Characterize ALK-rearranged Lung Adenocarcinoma in the Western Population (2009, background): “Non–small cell lung cancer (NSCLC) accounts for∼85% of lung cancer cases (3, 4).”
A PRACTICAL GUIDE TO UNDERSTANDING KAPLAN-MEIER CURVES (2010, background): “For example, in a study looking at the survival of patients receiving treatment for stage I lung cancer, the median follow-up was 40 months.(4) However, one of the 302 patients had a follow-up at 10 years, and so a survival rate of 92 percent (95% confidence interval [CI] 88-95%) at 10 years was pre”
Cancer risks from diagnostic radiology. (2008, background): “The potential mortality benefits of lung cancer screening have been much debated [72, 73], and it is fair to say that, at the very earliest, the issue will not be resolved until the completion of the National Lung Cancer Table 2.”